Medical Uses of Radioactive Material | Midpage

Collections
Arizona Administrative Code

7

Medical Uses of Radioactive Material

Department of Health Services - Radiation Control

R9-7-701License Required R9-7-702Definitions R9-7-703License for Medical Use of Radioactive Material R9-7-704Provisions for the Protection of Human Research Subjects R9-7-705Authority and Responsibilities for the Radiation Protection Program R9-7-706Supervision R9-7-707Written Directives R9-7-708Procedures for Administrations Requiring a Written Directive R9-7-709Sealed Sources or Devices for Medical Use R9-7-710Radiation Safety Officer and Associate Radiation Safety Officer Training R9-7-711Authorized Medical Physicist Training R9-7-712Authorized Nuclear Pharmacist Training R9-7-712.01Training for Experienced Radiation Safety Officers, Teletherapy or Medical Physicists, Authorized Medical Physicists, Authorized Users, Nuclear Pharmacists, and Authorized Nuclear Pharmacists R9-7-713Determination of Prescribed Dosages, and Possession, Use, and Calibration of Instruments R9-7-714Authorization for Calibration, Transmission, and Reference Sources R9-7-715Requirements for Possession of Sealed Sources and Brachytherapy Sources R9-7-716Surveys of Ambient Radiation Exposure Rate, Surveys for Contamination, and PET Radiation Exposure Concerns R9-7-717Release of Individuals Containing Radioactive Material or Implants Containing Radioactive Material R9-7-718Mobile Medical Service R9-7-719Training for Uptake, Dilution, and Excretion Studies R9-7-720Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations R9-7-721Training for Imaging and Localization Studies Not Requiring a Written Directive R9-7-722Safety Instruction and Precautions for Use of Unsealed Radioactive Material Requiring a Written Directive R9-7-723Training for Use of Unsealed Radioactive Material Requiring a Written Directive, Including Treatment of Hyperthyroidism, and Treatment of Thyroid Carcinoma R9-7-724Surveys after Brachytherapy Source Implant and Removal; Accountability R9-7-725Safety Instructions and Precautions for Brachytherapy Patients that Cannot be Released Under R9-7-717 R9-7-726Calibration Measurements of Brachytherapy Sources, Decay of Sources Used for Ophthalmic Treatments, and Computerized Treatment Planning Systems R9-7-727Training for Use of Manual Brachytherapy Sources and Training for the Use of Strontium-90 Sources for Treatment of Ophthalmic Disease R9-7-728Training for Use of Sealed Sources for Diagnosis R9-7-729Surveys of Patients and Human Research Subjects Treated with a Remote Afterloader Unit R9-7-730Installation, Maintenance, Adjustment, and Repair of an Afterloader Unit, Teletherapy Unit, or Gamma Stereotactic Radiosurgery Unit R9-7-731Safety Procedures and Instructions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units R9-7-732Safety Precautions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units R9-7-733Dosimetry Equipment R9-7-734Full Calibration Measurements on Teletherapy Units R9-7-735Full Calibration Measurements on Remote Afterloader Units R9-7-736Full Calibration Measurements on Gamma Stereotactic Radiosurgery Units R9-7-737Periodic Spot-checks for Teletherapy Units R9-7-738Periodic Spot-checks for Remote Afterloader Units R9-7-739Periodic Spot-checks for Gamma Stereotactic Radiosurgery Units R9-7-740Additional Requirements for Mobile Remote Afterloader Units R9-7-741Additional Radiation Surveys of Sealed Sources used in Radiation Therapy R9-7-742Five-year Inspection for Teletherapy and Gamma Stereotactic Radiosurgery Units R9-7-743Therapy-related Computer Systems R9-7-744Training for Use of Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units R9-7-745Report and Notification of a Medical Event R9-7-746Report and Notification of a Dose to an Embryo, Fetus, or Nursing Child